MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales or maturities of
marketable securities
$39,046K
Sales of property and
equipment and other assets
$1,170K
Proceeds from the
issuance of common stock...
$23K
Net cash provided by
(used in) investing...
$40,216K
Net cash provided by
(used in) financing...
$23K
Net increase
(decrease) in cash and cash...
$8,730K
Canceled cashflow
$31,509K
Impairment of long-lived
assets
$6,145K
Non-refundable sublicense and
transition services...
$4,015K
Sharebased compensation
$3,001K
Accounts payable
$1,880K
Depreciation and
amortization
$728K
Prepaid research and
development
-$391K
Prepaid expenses and
other current assets,...
-$228K
Amortization of premium and
discount on marketable...
$129K
Other non-cash items
$14K
Net cash provided by
(used in) operating...
-$31,509K
Canceled cashflow
$16,531K
Net loss
-$45,522K
Accrued expenses and
other current...
-$2,054K
Right of use assets and
operating lease...
$464K
Back
Back
Cash Flow
source: myfinsight.com
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)